Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Operating Income: 2017-2025

Historic Operating Income for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $20.7 million.

  • Organogenesis Holdings' Operating Income rose 232.06% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 34.41%. This contributed to the annual value of -$1.3 million for FY2024, which is 110.24% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Operating Income stood at $20.7 million, which was up 264.81% from -$12.6 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Operating Income high stood at $23.6 million for Q2 2021, and its period low was -$26.7 million during Q1 2025.
  • For the 3-year period, Organogenesis Holdings' Operating Income averaged around -$668,455, with its median value being -$1.3 million (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Operating Income surged by 1,147.38% in 2021, and later tumbled by 3,025.78% in 2023.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Operating Income stood at $19.8 million in 2021, then crashed by 55.86% to $8.7 million in 2022, then crashed by 114.56% to -$1.3 million in 2023, then soared by 905.28% to $10.2 million in 2024, then surged by 232.06% to $20.7 million in 2025.
  • Its Operating Income was $20.7 million in Q3 2025, compared to -$12.6 million in Q2 2025 and -$26.7 million in Q1 2025.